November 26, 2021
CLO-MD 0.5 by Kentapil Pharma contains Clonazepam 0.5 mg in a mouth-dissolving tablet formulation. It is a benzodiazepine medicine used for specific seizure disorders and panic disorder. It should be taken only under qualified medical supervision and prescribed guidance.
CLO-MD 0.5 by Kentapil Pharma contains Clonazepam 0.5 mg in a convenient mouth-dissolving tablet formulation. Clonazepam is a benzodiazepine medicine with anticonvulsant and anxiolytic properties and is prescribed for specific seizure disorders and panic disorder. The mouth-dissolving format provides convenient administration when clinically appropriate. Because clonazepam can cause drowsiness, impaired coordination, and dependence, it should be used strictly according to a qualified healthcare professional’s instructions. Combining benzodiazepines with opioids or other central nervous system depressants can cause severe sedation and respiratory depression. Long-term use should not be stopped abruptly; dose reduction should be gradual under medical supervision.
CLO-ES by Kentapil Pharma combines Escitalopram Oxalate 10 mg and Clonazepam 0.5 mg in a convenient tablet. It is prescribed for selected anxiety and depressive conditions, providing antidepressant and calming effects under qualified healthcare-professional supervision and individualized treatment guidance.
CLO-ES by Kentapil Pharma combines Escitalopram Oxalate 10 mg and Clonazepam 0.5 mg in an oral tablet formulation. Escitalopram is a selective serotonin reuptake inhibitor (SSRI) used for major depressive disorder and generalized anxiety disorder, while Clonazepam is a benzodiazepine with anxiolytic and anticonvulsant properties. This combination may be prescribed for selected patients requiring management of anxiety or depressive symptoms with associated anxiety. CLO-ES should be used strictly according to the dosage and duration prescribed by a qualified healthcare professional. Clonazepam may cause drowsiness, dependence, and withdrawal symptoms, while antidepressant therapy requires appropriate monitoring. Avoid alcohol and other sedating medicines unless medically advised.
CLO-BETA is a prescription tablet containing clonazepam 0.5 mg and propranolol 20 mg. It combines a benzodiazepine with a beta blocker. Use only under medical supervision, as both medicines can cause clinically important effects and require individualized dosing and monitoring.
CLO-BETA is a prescription combination tablet from Kentapil Pharma containing clonazepam 0.5 mg and propranolol 20 mg. Clonazepam is a benzodiazepine that reduces excessive nervous system activity, while propranolol is a beta blocker that influences heart rate and blood pressure. The combination may be prescribed for selected patients with anxiety-related symptoms when a healthcare professional considers both components appropriate. It should be taken only in the prescribed dose and duration. Clonazepam may cause drowsiness and dependence, while combined use can contribute to dizziness, low blood pressure, or pulse changes. Patients should avoid self-medication, alcohol, and abrupt discontinuation and follow medical guidance.
NORMASOL is a prescription combination tablet from Kentapil Pharma containing chlordiazepoxide 5 mg, clidinium bromide 2.5 mg and dicyclomine HCl 10 mg. Its components provide anxiolytic and antispasmodic actions and should be used only under appropriate medical supervision.
NORMASOL is a prescription combination tablet from Kentapil Pharma formulated with chlordiazepoxide 5 mg, clidinium bromide 2.5 mg and dicyclomine HCl 10 mg. The formulation combines a benzodiazepine with two anticholinergic antispasmodic agents. Chlordiazepoxide may help reduce excessive nervous-system activity, while clidinium and dicyclomine can reduce gastrointestinal smooth-muscle spasms. The product may be prescribed for selected gastrointestinal conditions when a healthcare professional determines that the combination is appropriate. NORMASOL should be taken strictly according to medical advice. Because chlordiazepoxide may cause sedation, dependence, and withdrawal effects, patients should avoid self-medication, alcohol, and abrupt discontinuation without professional guidance.
SOLANXIT-FM is a prescription combination tablet from Kentapil Pharma containing Flupentixol 0.5 mg and Melitracen 10 mg. It combines complementary pharmacological actions and may be prescribed for selected anxiety- and depression-related conditions under appropriate medical supervision.
SOLANXIT-FM is a prescription combination tablet from Kentapil Pharma containing Flupentixol 0.5 mg and Melitracen 10 mg. Flupentixol belongs to the thioxanthene class, while Melitracen is a tricyclic antidepressant. The combination is used in selected patients with anxiety and depression-related conditions, as determined by a qualified healthcare professional. Its formulation provides complementary pharmacological actions intended to support appropriate symptom management. SOLANXIT-FM should be taken strictly according to the prescribed dose and duration. Patients should not self-medicate or discontinue treatment without medical advice. Appropriate evaluation is recommended before use, particularly in patients with relevant cardiovascular, neurological, or other medical conditions.
SOLANXIT-0.5 is a prescription tablet from Kentapil Pharma containing Flupentixol 0.5 mg. It belongs to the thioxanthene class of medicines and may be prescribed for selected psychiatric conditions. Use strictly according to medical advice and prescribed dosage.
SOLANXIT-0.5 is a prescription tablet from Kentapil Pharma containing Flupentixol 0.5 mg. Flupentixol belongs to the thioxanthene class of antipsychotic medicines and acts on neurotransmitter activity within the central nervous system. Depending on the clinical assessment and approved indication, low-dose oral flupentixol may be prescribed for selected depressive conditions, while higher doses are used for psychotic disorders. SOLANXIT-0.5 should be taken only in the dose and duration recommended by a qualified healthcare professional. Patients should not alter or discontinue treatment without medical guidance. Appropriate monitoring may be required to assess therapeutic response and potential adverse effects during treatment.
ETISOL 0.5 is a prescription tablet from Kentapil Pharma containing Etizolam 0.50 mg. It belongs to the thienodiazepine class and is used under medical supervision for selected anxiety-related conditions. Appropriate dosing and duration should always be determined by a qualified healthcare professional.
ETISOL 0.5 is a prescription tablet from Kentapil Pharma containing Etizolam 0.50 mg. Etizolam belongs to the thienodiazepine class and produces central nervous system depressant effects. It may be prescribed by healthcare professionals for selected anxiety-related conditions based on individual clinical assessment. ETISOL 0.5 should be taken strictly according to the prescribed dose and duration. Patients should not self-medicate, increase the dose, or discontinue treatment suddenly without medical guidance. As with benzodiazepine-related medicines, inappropriate or prolonged use may result in dependence and withdrawal symptoms. Patients should also avoid alcohol and other central nervous system depressants unless specifically advised by their doctor.
ETISOL-PLUS is a prescription combination tablet from Kentapil Pharma containing Etizolam 0.5 mg and Propranolol 20 mg. It combines calming and beta-blocking actions and may be prescribed for selected anxiety-related conditions under appropriate medical supervision and individualized dosing.
ETISOL-PLUS is a prescription combination tablet from Kentapil Pharma containing Etizolam 0.5 mg and Propranolol 20 mg. Etizolam belongs to the thienodiazepine class and helps reduce excessive central nervous system activity, while Propranolol is a beta blocker that reduces the effects of certain chemical messengers on the heart and blood vessels. The combination may be prescribed for selected anxiety-related conditions and associated physical symptoms. ETISOL-PLUS should be used only according to a qualified healthcare professional’s instructions. Patients should not self-medicate, change the prescribed dose, or discontinue treatment abruptly. Drowsiness, tiredness, and slow heart rate may occur.
TRIZINE-C by Kentapil Pharma combines Chlordiazepoxide 10 mg and Trifluoperazine 1 mg in a tablet formulation. It is prescribed for selected psychiatric conditions requiring management of anxiety and related symptoms, providing calming and antipsychotic effects under qualified medical supervision.
TRIZINE-C by Kentapil Pharma contains Chlordiazepoxide 10 mg and Trifluoperazine 1 mg in an oral tablet formulation. Chlordiazepoxide is a benzodiazepine that provides anxiolytic and calming effects, while Trifluoperazine is a phenothiazine antipsychotic used for selected psychiatric conditions. This combination may be prescribed for specific patients requiring management of anxiety and associated psychiatric symptoms. TRIZINE-C should be taken strictly according to the dosage and duration prescribed by a qualified healthcare professional. Both medicines can cause drowsiness, dizziness, or impaired coordination, and their combined use may increase central nervous system depression. Avoid alcohol and activities requiring alertness unless medically advised. Do not discontinue treatment without professional guidance.
CINADOMP by Kentapil Pharma combines Cinnarizine 20 mg and Domperidone 15 mg in a tablet formulation. It is designed for prescribed management of nausea, vomiting, and motion-related symptoms, providing antihistaminic and antiemetic effects under qualified healthcare-professional supervision.
CINADOMP by Kentapil Pharma combines Cinnarizine 20 mg and Domperidone 15 mg in an oral tablet formulation. Cinnarizine is an antihistamine with properties used in the management of motion-related symptoms, while Domperidone is an antiemetic that helps relieve nausea and vomiting. The combination may be prescribed for selected patients experiencing nausea, vomiting, or motion-related discomfort. CINADOMP provides convenient oral administration and should be used only according to the dosage and duration recommended by a qualified healthcare professional. Domperidone requires particular caution because of potential cardiac risks and drug interactions; it should be used at the lowest effective dose for the shortest appropriate duration.
VOTOZ-MD 4/8 by Kentapil Pharma contains Ondansetron Hydrochloride in 4 mg and 8 mg strengths. It is an antiemetic medicine used to prevent nausea and vomiting associated with selected treatments and procedures, offering convenient mouth-dissolving administration as prescribed.
VOTOZ-MD 4/8 by Kentapil Pharma contains Ondansetron Hydrochloride, available in 4 mg and 8 mg mouth-dissolving tablet strengths. Ondansetron is a selective 5-HT3 receptor antagonist used to prevent nausea and vomiting associated with certain cancer chemotherapy, radiotherapy, and postoperative situations. The mouth-dissolving formulation provides convenient administration for patients who may have difficulty swallowing conventional tablets. VOTOZ-MD 4/8 offers flexible strength options according to individual treatment requirements. It should be used strictly according to the dosage and duration recommended by a qualified healthcare professional. Ondansetron may cause headache, constipation, and other adverse effects and requires appropriate caution in patients with certain heart rhythm conditions.
PROLAM by Kentapil Pharma combines Alprazolam 0.25 mg and Propranolol 20 mg in a tablet formulation. It may be prescribed for selected anxiety-related conditions, helping address anxiety and associated physical symptoms under qualified healthcare-professional supervision and individualized treatment guidance.
PROLAM by Kentapil Pharma combines Alprazolam 0.25 mg and Propranolol 20 mg in an oral tablet formulation. Alprazolam is a benzodiazepine used for the short-term treatment of generalized anxiety disorder and panic disorder, while Propranolol is a beta-blocker that can help control certain physical effects associated with adrenaline, such as increased heart rate. This combination may be prescribed for selected patients when clinically appropriate. PROLAM should be taken strictly according to the dosage and duration recommended by a qualified healthcare professional. Alprazolam may cause drowsiness, dependence, and withdrawal symptoms, while Propranolol may affect heart rate and blood pressure.
Kentapil Pharma, A Sri Ganganagar-based pharmaceutical company established in 2004, delivers trusted, high-quality medicines and healthcare products with reliable nationwide service to clients across India.
Copyright © 2026 Kentapil Pharma, All rights reserved.
This website uses cookies to provide you with the best browsing experience.